nodes	percent_of_prediction	percent_of_DWPC	metapath
Tobramycin—Ocular toxicity—Carmustine—malignant glioma	0.103	0.103	CcSEcCtD
Tobramycin—Conjunctival oedema—Carmustine—malignant glioma	0.0504	0.0504	CcSEcCtD
Tobramycin—Nephrotoxicity—Carmustine—malignant glioma	0.044	0.044	CcSEcCtD
Tobramycin—Nephropathy toxic—Carmustine—malignant glioma	0.0243	0.0243	CcSEcCtD
Tobramycin—Transaminases increased—Carmustine—malignant glioma	0.023	0.023	CcSEcCtD
Tobramycin—Lung disorder—Temozolomide—malignant glioma	0.0191	0.0191	CcSEcCtD
Tobramycin—Injection site pain—Carmustine—malignant glioma	0.0171	0.0171	CcSEcCtD
Tobramycin—Drug interaction—Carmustine—malignant glioma	0.0151	0.0151	CcSEcCtD
Tobramycin—Leukocytosis—Carmustine—malignant glioma	0.0149	0.0149	CcSEcCtD
Tobramycin—Hearing impaired—Temozolomide—malignant glioma	0.0142	0.0142	CcSEcCtD
Tobramycin—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.0135	0.0135	CcSEcCtD
Tobramycin—Dry eye—Temozolomide—malignant glioma	0.0125	0.0125	CcSEcCtD
Tobramycin—Thrombophlebitis—Carmustine—malignant glioma	0.0117	0.0117	CcSEcCtD
Tobramycin—Swelling—Carmustine—malignant glioma	0.0115	0.0115	CcSEcCtD
Tobramycin—Ear pain—Temozolomide—malignant glioma	0.0115	0.0115	CcSEcCtD
Tobramycin—Thrombophlebitis—Temozolomide—malignant glioma	0.0113	0.0113	CcSEcCtD
Tobramycin—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.0113	0.0113	CcSEcCtD
Tobramycin—Eye pain—Carmustine—malignant glioma	0.0112	0.0112	CcSEcCtD
Tobramycin—Deafness—Temozolomide—malignant glioma	0.011	0.011	CcSEcCtD
Tobramycin—Eye pain—Temozolomide—malignant glioma	0.0109	0.0109	CcSEcCtD
Tobramycin—Nasal congestion—Temozolomide—malignant glioma	0.0108	0.0108	CcSEcCtD
Tobramycin—Dermatitis exfoliative—Temozolomide—malignant glioma	0.0104	0.0104	CcSEcCtD
Tobramycin—Hypokalaemia—Carmustine—malignant glioma	0.00923	0.00923	CcSEcCtD
Tobramycin—Dehydration—Temozolomide—malignant glioma	0.00912	0.00912	CcSEcCtD
Tobramycin—Dry skin—Temozolomide—malignant glioma	0.00899	0.00899	CcSEcCtD
Tobramycin—Muscular weakness—Carmustine—malignant glioma	0.00895	0.00895	CcSEcCtD
Tobramycin—Hypokalaemia—Temozolomide—malignant glioma	0.00892	0.00892	CcSEcCtD
Tobramycin—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00883	0.00883	CcSEcCtD
Tobramycin—Muscular weakness—Temozolomide—malignant glioma	0.00865	0.00865	CcSEcCtD
Tobramycin—Bronchitis—Temozolomide—malignant glioma	0.00815	0.00815	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00788	0.00788	CcSEcCtD
Tobramycin—Renal failure—Carmustine—malignant glioma	0.00769	0.00769	CcSEcCtD
Tobramycin—Weight decreased—Temozolomide—malignant glioma	0.00767	0.00767	CcSEcCtD
Tobramycin—Neuropathy peripheral—Carmustine—malignant glioma	0.00766	0.00766	CcSEcCtD
Tobramycin—Stomatitis—Carmustine—malignant glioma	0.00762	0.00762	CcSEcCtD
Tobramycin—Infestation NOS—Temozolomide—malignant glioma	0.00756	0.00756	CcSEcCtD
Tobramycin—Infestation—Temozolomide—malignant glioma	0.00756	0.00756	CcSEcCtD
Tobramycin—Neuropathy peripheral—Temozolomide—malignant glioma	0.00741	0.00741	CcSEcCtD
Tobramycin—Stomatitis—Temozolomide—malignant glioma	0.00737	0.00737	CcSEcCtD
Tobramycin—Sinusitis—Temozolomide—malignant glioma	0.00709	0.00709	CcSEcCtD
Tobramycin—Connective tissue disorder—Carmustine—malignant glioma	0.0069	0.0069	CcSEcCtD
Tobramycin—Visual impairment—Carmustine—malignant glioma	0.00676	0.00676	CcSEcCtD
Tobramycin—Pharyngitis—Temozolomide—malignant glioma	0.00673	0.00673	CcSEcCtD
Tobramycin—Urinary tract disorder—Temozolomide—malignant glioma	0.0067	0.0067	CcSEcCtD
Tobramycin—Connective tissue disorder—Temozolomide—malignant glioma	0.00667	0.00667	CcSEcCtD
Tobramycin—Urethral disorder—Temozolomide—malignant glioma	0.00665	0.00665	CcSEcCtD
Tobramycin—Eye disorder—Carmustine—malignant glioma	0.00656	0.00656	CcSEcCtD
Tobramycin—Visual impairment—Temozolomide—malignant glioma	0.00654	0.00654	CcSEcCtD
Tobramycin—Eye disorder—Temozolomide—malignant glioma	0.00634	0.00634	CcSEcCtD
Tobramycin—Tinnitus—Temozolomide—malignant glioma	0.00632	0.00632	CcSEcCtD
Tobramycin—Angiopathy—Temozolomide—malignant glioma	0.00615	0.00615	CcSEcCtD
Tobramycin—Immune system disorder—Temozolomide—malignant glioma	0.00613	0.00613	CcSEcCtD
Tobramycin—Mediastinal disorder—Temozolomide—malignant glioma	0.00611	0.00611	CcSEcCtD
Tobramycin—Erythema—Carmustine—malignant glioma	0.00611	0.00611	CcSEcCtD
Tobramycin—Back pain—Carmustine—malignant glioma	0.00591	0.00591	CcSEcCtD
Tobramycin—Erythema—Temozolomide—malignant glioma	0.0059	0.0059	CcSEcCtD
Tobramycin—Dysgeusia—Temozolomide—malignant glioma	0.00578	0.00578	CcSEcCtD
Tobramycin—Vision blurred—Carmustine—malignant glioma	0.00576	0.00576	CcSEcCtD
Tobramycin—Back pain—Temozolomide—malignant glioma	0.00571	0.00571	CcSEcCtD
Tobramycin—Anaemia—Carmustine—malignant glioma	0.00565	0.00565	CcSEcCtD
Tobramycin—Vision blurred—Temozolomide—malignant glioma	0.00556	0.00556	CcSEcCtD
Tobramycin—Ill-defined disorder—Temozolomide—malignant glioma	0.00548	0.00548	CcSEcCtD
Tobramycin—Leukopenia—Carmustine—malignant glioma	0.00547	0.00547	CcSEcCtD
Tobramycin—Anaemia—Temozolomide—malignant glioma	0.00546	0.00546	CcSEcCtD
Tobramycin—Angioedema—Temozolomide—malignant glioma	0.0054	0.0054	CcSEcCtD
Tobramycin—Malaise—Temozolomide—malignant glioma	0.00532	0.00532	CcSEcCtD
Tobramycin—Vertigo—Temozolomide—malignant glioma	0.00531	0.00531	CcSEcCtD
Tobramycin—Leukopenia—Temozolomide—malignant glioma	0.00529	0.00529	CcSEcCtD
Tobramycin—Chest pain—Carmustine—malignant glioma	0.0052	0.0052	CcSEcCtD
Tobramycin—Myalgia—Carmustine—malignant glioma	0.0052	0.0052	CcSEcCtD
Tobramycin—Cough—Temozolomide—malignant glioma	0.00515	0.00515	CcSEcCtD
Tobramycin—Confusional state—Carmustine—malignant glioma	0.00503	0.00503	CcSEcCtD
Tobramycin—Myalgia—Temozolomide—malignant glioma	0.00503	0.00503	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00499	0.00499	CcSEcCtD
Tobramycin—Discomfort—Temozolomide—malignant glioma	0.00497	0.00497	CcSEcCtD
Tobramycin—Thrombocytopenia—Carmustine—malignant glioma	0.00488	0.00488	CcSEcCtD
Tobramycin—Confusional state—Temozolomide—malignant glioma	0.00486	0.00486	CcSEcCtD
Tobramycin—Anaphylactic shock—Temozolomide—malignant glioma	0.00482	0.00482	CcSEcCtD
Tobramycin—Anorexia—Carmustine—malignant glioma	0.00475	0.00475	CcSEcCtD
Tobramycin—Nervous system disorder—Temozolomide—malignant glioma	0.00473	0.00473	CcSEcCtD
Tobramycin—Thrombocytopenia—Temozolomide—malignant glioma	0.00472	0.00472	CcSEcCtD
Tobramycin—Skin disorder—Temozolomide—malignant glioma	0.00468	0.00468	CcSEcCtD
Tobramycin—Anorexia—Temozolomide—malignant glioma	0.00459	0.00459	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00454	0.00454	CcSEcCtD
Tobramycin—Paraesthesia—Carmustine—malignant glioma	0.00448	0.00448	CcSEcCtD
Tobramycin—Dyspnoea—Carmustine—malignant glioma	0.00445	0.00445	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00439	0.00439	CcSEcCtD
Tobramycin—Decreased appetite—Carmustine—malignant glioma	0.00433	0.00433	CcSEcCtD
Tobramycin—Paraesthesia—Temozolomide—malignant glioma	0.00433	0.00433	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Carmustine—malignant glioma	0.00431	0.00431	CcSEcCtD
Tobramycin—Dyspnoea—Temozolomide—malignant glioma	0.0043	0.0043	CcSEcCtD
Tobramycin—Pain—Carmustine—malignant glioma	0.00426	0.00426	CcSEcCtD
Tobramycin—Decreased appetite—Temozolomide—malignant glioma	0.00419	0.00419	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00416	0.00416	CcSEcCtD
Tobramycin—Pain—Temozolomide—malignant glioma	0.00412	0.00412	CcSEcCtD
Tobramycin—Feeling abnormal—Carmustine—malignant glioma	0.00411	0.00411	CcSEcCtD
Tobramycin—Gastrointestinal pain—Carmustine—malignant glioma	0.00408	0.00408	CcSEcCtD
Tobramycin—Feeling abnormal—Temozolomide—malignant glioma	0.00397	0.00397	CcSEcCtD
Tobramycin—Abdominal pain—Carmustine—malignant glioma	0.00394	0.00394	CcSEcCtD
Tobramycin—Body temperature increased—Carmustine—malignant glioma	0.00394	0.00394	CcSEcCtD
Tobramycin—Gastrointestinal pain—Temozolomide—malignant glioma	0.00394	0.00394	CcSEcCtD
Tobramycin—Urticaria—Temozolomide—malignant glioma	0.00383	0.00383	CcSEcCtD
Tobramycin—Abdominal pain—Temozolomide—malignant glioma	0.00381	0.00381	CcSEcCtD
Tobramycin—Body temperature increased—Temozolomide—malignant glioma	0.00381	0.00381	CcSEcCtD
Tobramycin—Hypersensitivity—Carmustine—malignant glioma	0.00367	0.00367	CcSEcCtD
Tobramycin—Asthenia—Carmustine—malignant glioma	0.00358	0.00358	CcSEcCtD
Tobramycin—Hypersensitivity—Temozolomide—malignant glioma	0.00355	0.00355	CcSEcCtD
Tobramycin—Asthenia—Temozolomide—malignant glioma	0.00346	0.00346	CcSEcCtD
Tobramycin—Diarrhoea—Carmustine—malignant glioma	0.00341	0.00341	CcSEcCtD
Tobramycin—Pruritus—Temozolomide—malignant glioma	0.00341	0.00341	CcSEcCtD
Tobramycin—Dizziness—Carmustine—malignant glioma	0.0033	0.0033	CcSEcCtD
Tobramycin—Diarrhoea—Temozolomide—malignant glioma	0.0033	0.0033	CcSEcCtD
Tobramycin—Dizziness—Temozolomide—malignant glioma	0.00319	0.00319	CcSEcCtD
Tobramycin—Vomiting—Carmustine—malignant glioma	0.00317	0.00317	CcSEcCtD
Tobramycin—Rash—Carmustine—malignant glioma	0.00314	0.00314	CcSEcCtD
Tobramycin—Dermatitis—Carmustine—malignant glioma	0.00314	0.00314	CcSEcCtD
Tobramycin—Headache—Carmustine—malignant glioma	0.00312	0.00312	CcSEcCtD
Tobramycin—Vomiting—Temozolomide—malignant glioma	0.00306	0.00306	CcSEcCtD
Tobramycin—Rash—Temozolomide—malignant glioma	0.00304	0.00304	CcSEcCtD
Tobramycin—Dermatitis—Temozolomide—malignant glioma	0.00304	0.00304	CcSEcCtD
Tobramycin—Headache—Temozolomide—malignant glioma	0.00302	0.00302	CcSEcCtD
Tobramycin—Nausea—Carmustine—malignant glioma	0.00296	0.00296	CcSEcCtD
Tobramycin—Nausea—Temozolomide—malignant glioma	0.00286	0.00286	CcSEcCtD
